Raymond James & Associates’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $12.8M | Buy |
35,751
+609
| +2% | +$206K | 0.01% | 1077 |
|
|
2024
Q2 | $11.2M | Buy |
35,142
+7,211
| +26% | +$1.91M | 0.01% | 1101 |
|
|
2024
Q1 | $6.42M | Sell |
27,931
-1,543
| -5% | -$348K | ﹤0.01% | 1414 |
|
|
2023
Q4 | $6.48M | Buy |
29,474
+1,420
| +5% | +$327K | ﹤0.01% | 1364 |
|
|
2023
Q3 | $6.34M | Buy |
28,054
+471
| +2% | +$108K | 0.01% | 1311 |
|
|
2023
Q2 | $6.09M | Sell |
27,583
-8,886
| -24% | -$1.97M | 0.01% | 1348 |
|
|
2023
Q1 | $8.17M | Sell |
36,469
-4,993
| -12% | -$1.23M | 0.01% | 1147 |
|
|
2022
Q4 | $11.5M | Sell |
41,462
-982
| -2% | -$248K | 0.01% | 917 |
|
|
2022
Q3 | $8.89M | Sell |
42,444
-5,425
| -11% | -$1.21M | 0.01% | 1036 |
|
|
2022
Q2 | $11.3M | Buy |
47,869
+12,180
| +34% | +$2.48M | 0.01% | 912 |
|
|
2022
Q1 | $6.4M | Sell |
35,689
-1,057
| -3% | -$201K | 0.01% | 1327 |
|
|
2021
Q4 | $7.94M | Sell |
36,746
-248
| -0.7% | -$48.7K | 0.01% | 1238 |
|
|
2021
Q3 | $6.83M | Buy |
36,994
+3,867
| +12% | +$762K | 0.01% | 1289 |
|
|
2021
Q2 | $5.94M | Buy |
33,127
+2,485
| +8% | +$473K | 0.01% | 1379 |
|
|
2021
Q1 | $5.13M | Buy |
30,642
+7,007
| +30% | +$1.17M | 0.01% | 1413 |
|
|
2020
Q4 | $3.59M | Buy |
23,635
+8,467
| +56% | +$1.11M | ﹤0.01% | 1525 |
|
|
2020
Q3 | $1.53M | Sell |
15,168
-2,314
| -13% | -$254K | ﹤0.01% | 1921 |
|
|
2020
Q2 | $2.12M | Buy |
+17,482
| New | +$1.97M | ﹤0.01% | 1705 |
|
|
2019
Q2 | – | Sell |
-2,662
| Closed | -$312K | – | 3755 |
|
|
2019
Q1 | $312K | Buy |
+2,662
| New | +$310K | ﹤0.01% | 2960 |
|
|
2018
Q4 | – | Sell |
-2,266
| Closed | -$290K | – | 3701 |
|
|
2018
Q3 | $290K | Sell |
2,266
-137
| -6% | -$16.9K | ﹤0.01% | 3054 |
|
|
2018
Q2 | $272K | Sell |
2,403
-503
| -17% | -$55.3K | ﹤0.01% | 3085 |
|
|
2018
Q1 | $327K | Buy |
2,906
+393
| +16% | +$49.9K | ﹤0.01% | 2835 |
|
|
2017
Q4 | $372K | Buy |
2,513
+40
| +2% | +$5.08K | ﹤0.01% | 2720 |
|
|
2017
Q3 | $290K | Sell |
2,473
-1,661
| -40% | -$212K | ﹤0.01% | 2819 |
|
|
2017
Q2 | $536K | Buy |
4,134
+2,231
| +117% | +$278K | ﹤0.01% | 2371 |
|
|
2017
Q1 | $258K | Sell |
1,903
-288
| -13% | -$43.6K | ﹤0.01% | 2787 |
|
|
2016
Q4 | $314K | Sell |
2,191
-134
| -6% | -$17.1K | ﹤0.01% | 2599 |
|
|
2016
Q3 | $275K | Buy |
+2,325
| New | +$279K | ﹤0.01% | 2680 |
|
|
2016
Q2 | – | Sell |
-1,898
| Closed | -$211K | – | 3096 |
|
|
2016
Q1 | $211K | Buy |
+1,898
| New | +$240K | ﹤0.01% | 2548 |
|
Other funds holding UTHR
ACA
